Market Tracker

01/30 6:05pm ET

Trovagene Inc (NASDAQ:TROV)

6.50
Data as of Jan 30
 +0.67 / +11.49%
Today’s Change
2.97
Today|||52-Week Range
7.10
+51.16%
Year-to-Date

Today’s Trading

Previous close5.83
Today’s open5.81
Day’s range5.80 - 6.69
Volume438,085
Average volume (3 months)101,486
Market cap$122.9M
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-9.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book6.03

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc0.000.00%
CGIXCancer Genetics Inc-0.21-2.69%
GALTGalectin Therapeutic...-0.23-6.67%
VCYTVeracyte Inc-0.21-2.53%
Data as of 3:59pm ET, 01/30/2015

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts